VitaNova Life Sciences (VNOV) Liabilities from Discontinued Operations (2018)

VitaNova Life Sciences (VNOV) reported Liabilities from Discontinued Operations of 5600.0 for Q2 2018.

VitaNova Life Sciences (VNOV) Liabilities from Discontinued Operations (2018) Analysis & Trends

VitaNova Life Sciences has reported Liabilities from Discontinued Operations for 1 years, with the latest figure at 5600.0 in Q2 2018.

  • For the quarter ending Q2 2018, Liabilities from Discontinued Operations changed N/A year-over-year to 5600.0; the trailing twelve-month figure through Apr 2018 stood at 5600.0 (changed N/A YoY), and the FY2018 full-year result was 5600.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations for Q2 2018 stood at 5600.0.
  • The five-year high for Liabilities from Discontinued Operations was 5600.0 in Q2 2018, with the low at 5600.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn
10 VitaNova Life Sciences - - 316,343.00

Historic Data

Download Data
DateValue
Apr 30, 2018 5,600.00
Apr 30, 2018 5,600.00